AQR Capital Management Portfolio holdings
AUM
$121B
1-Year Return
23.38%
This Quarter Return
+1%
1 Year Return
+23.38%
3 Year Return
+85.44%
5 Year Return
+156.19%
10 Year Return
+370.97%
AUM
$65.2B
AUM Growth
+$6.51B
(+11%)
Cap. Flow
+$6.33B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
15.4%
Holding
2,716
New
313
Increased
1,389
Reduced
876
Closed
123
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$211M |
| 2 |
Cigna
CI
|
+$198M |
| 3 |
Comcast
CMCSA
|
+$163M |
| 4 |
Zoom
ZM
|
+$148M |
| 5 |
Johnson & Johnson
JNJ
|
+$136M |
Top Sells
| 1 |
Humana
HUM
|
+$263M |
| 2 |
TSMC
TSM
|
+$245M |
| 3 |
NVIDIA
NVDA
|
+$168M |
| 4 |
Adobe
ADBE
|
+$151M |
| 5 |
Pultegroup
PHM
|
+$120M |
Sector Composition
| 1 | Technology | 24.6% |
| 2 | Financials | 13.87% |
| 3 | Consumer Discretionary | 12.44% |
| 4 | Industrials | 12.41% |
| 5 | Healthcare | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
ENI
E
$52.4B
| $533K | ﹤0.01% |
17,303
+676
| +4% | +$20.8K |
|
2027
iShares Select Dividend ETF
DVY
$20.8B
| $529K | ﹤0.01% |
4,376
| – | – |
|
2028
Construction Partners
ROAD
$7.02B
| $529K | ﹤0.01% |
9,574
+1,912
| +25% | +$106K |
|
2029
Magnolia Oil & Gas
MGY
$4.41B
| $528K | ﹤0.01% |
20,832
+4,276
| +26% | +$108K |
|
2030
Vanguard Information Technology ETF
VGT
$103B
| $527K | ﹤0.01% |
914
+280
| +44% | +$161K |
|
2031
MarineMax
HZO
$556M
| $524K | ﹤0.01% |
16,202
+4,905
| +43% | +$159K |
|
2032
Privia Health
PRVA
$2.8B
| $523K | ﹤0.01% |
30,081
-1,729
| -5% | -$30.1K |
|
2033
Macerich
MAC
$4.58B
| $523K | ﹤0.01% |
34,340
-35,504
| -51% | -$540K |
|
2034
Daily Journal
DJCO
$562M
| $519K | ﹤0.01% |
+1,316
| New | +$519K |
|
2035
Shoe Carnival
SCVL
$636M
| $519K | ﹤0.01% |
14,066
-5,214
| -27% | -$192K |
|
2036
Piper Sandler
PIPR
$6.12B
| $519K | ﹤0.01% |
2,254
+222
| +11% | +$51.1K |
|
2037
Rio Tinto
RIO
$101B
| $518K | ﹤0.01% |
+7,852
| New | +$518K |
|
2038
Silicon Laboratories
SLAB
$4.39B
| $517K | ﹤0.01% |
4,676
-704
| -13% | -$77.9K |
|
2039
Usana Health Sciences
USNA
$557M
| $517K | ﹤0.01% |
11,428
-3,293
| -22% | -$149K |
|
|
RVNC
2040
DELISTED
Revance Therapeutics, Inc.
RVNC
| $517K | ﹤0.01% |
201,080
+170,960
| +568% | +$439K |
|
2041
Vanguard Tax-Exempt Bond Index Fund
VTEB
$38.8B
| $516K | ﹤0.01% |
+10,296
| New | +$516K |
|
2042
Symbotic
SYM
$5.32B
| $514K | ﹤0.01% |
+14,612
| New | +$514K |
|
2043
Amplitude
AMPL
$1.47B
| $513K | ﹤0.01% |
57,678
-31,653
| -35% | -$282K |
|
2044
First Financial Bankshares
FFIN
$5.12B
| $511K | ﹤0.01% |
17,468
+2,379
| +16% | +$69.7K |
|
2045
Myriad Genetics
MYGN
$674M
| $511K | ﹤0.01% |
20,910
+3,116
| +18% | +$76.2K |
|
2046
Esquire Financial Holdings
ESQ
$828M
| $511K | ﹤0.01% |
10,734
-69
| -0.6% | -$3.28K |
|
2047
ZipRecruiter
ZIP
$419M
| $509K | ﹤0.01% |
55,979
+22,659
| +68% | +$206K |
|
|
ORAN
2048
DELISTED
Orange
ORAN
| $509K | ﹤0.01% |
50,904
+34,812
| +216% | +$348K |
|
2049
UroGen Pharma
URGN
$869M
| $508K | ﹤0.01% |
30,290
-11,972
| -28% | -$201K |
|
2050
Vanguard Value ETF
VTV
$145B
| $508K | ﹤0.01% |
3,167
+1,566
| +98% | +$251K |
|